Certolizumab pegol Available Phase N/A Trials for Crohn's Disease (CD)

IndicationsStatusPurposePhase
AvailableNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03559660CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)